Companies Dominating the Zellweger Spectrum Disorder Landscape
- Invitae Corporations.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CENTOGENE N.V.
- GeneDx, LLC
- Blueprint Genetics Oy
- Siemens Healthcare Gmbh
- Carestream Health, Inc.
- Agfa-Gevaert Group
- Shimadzu Corporation
- Asper Biogene LLC
- Trivitron Healthcare
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of zellweger spectrum disorder is assessed at USD 90.85 million.
Zellweger Spectrum Disorder Market size was valued at USD 86.37 million in 2024 and is expected to reach USD 186.49 million by 2037, registering around 6.1% CAGR during the forecast period i.e., between 2025-2037.
North America industry is likely to account for largest revenue share by 2037, on the back of impeccable research and healthcare infrastructure.
The major players in the market are GeneDx, LLC, Blueprint Genetics Oy., Siemens Healthcare Gmbh, Carestream Health Inc, and Agfa-Gevaert Group.
